Immediate Access for the Terminally Ill Act
Summary
HR7104 is an early-stage bill that modifies SSDI benefit timing for terminally ill beneficiaries without authorizing new spending. It remains in the House Ways and Means Committee with no hearings or markup scheduled. Market impact is negligible given the bill's procedural status, lack of appropriated funds, and narrow focus on benefit acceleration rather than new program creation.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR7104 is in the earliest legislative stage with no committee action since referral.
- 2.Zero new spending authorized — only modifies timing of existing SSA disbursements.
- 3.No publicly traded company has material exposure to this bill's mechanism.
- 4.Bill affects a narrow population (terminally ill SSDI beneficiaries) with no third-party contracting.
Market Implications
No market implications at this stage. The bill does not authorize contracts, grants, tax credits, or regulatory changes that would affect any publicly traded company's revenue or cost structure. If the bill were to advance (e.g., committee markup), the only potential indirect effect would be a minor administrative burden on SSA systems integrators like $LDOS or $SAIC if IT systems need modification — but the bill's scope is too narrow to trigger meaningful modernization spending. Investors should not allocate capital based on this bill in its current form.
Full Analysis
HR7104 (Immediate Access for the Terminally Ill Act) was introduced on January 15, 2026, and referred to the House Committee on Ways and Means. The bill permits terminally ill SSDI beneficiaries with conditions on the Compassionate Allowances list to elect expedited benefits in exchange for reduced monthly payments. No new funding is authorized; the mechanism is purely a timing shift of existing Social Security outlays. The bill has an identical companion, S3648, in the Senate which has also been referred to the Finance Committee. Both bills have seen zero additional legislative actions since referral, indicating no current momentum. No publicly traded company has direct exposure to SSDI benefit timing. Insurance companies (e.g., $UNH, $MET, $PRU) could see minor administrative adjustments if private disability products reference SSA timing, but the bill explicitly only covers Title II disability insurance benefits — not private insurance. No tickers warrant inclusion because no company faces a material change in revenue, costs, or competitive position from a benefit acceleration for a small subset of SSDI recipients. The bill language lacks any contracting mechanism, grant program, or regulatory change that would create a market signal.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Living Donor Protection Act of 2025
Consolidated Appropriations Act, 2026
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $1.1B Department of Veterans Affairs Contract
Protecting Health Care and Lowering Costs Act of 2025
TRIWEST HEALTHCARE ALLIANCE CORP: $820M Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $724M Department of Veterans Affairs Contract
Medicare for All Act
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $609M Department of Veterans Affairs Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →